Merit Medical Systems | MMSI - Selling And Administration Expenses

Stock Price
82.21
Daily Change
0.37 0.45%
Monthly
-1.49%
Yearly
-20.31%
Q1 Forecast
79.66

Merit Medical Systems reported $107.38M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
3M USD 965M 145M Dec/2025
Abbott USD 3.13B 125M Dec/2025
AngioDynamics USD 35.99M 14K Feb/2025
Anika Therapeutics USD 12.91M 17.8M Mar/2025
AtriCure USD 78.34M 109K Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Cooper Companies USD 419.2M 12M Sep/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
Globus Medical USD 313.6M 9.98M Sep/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
J&J USD 6.75B 831M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Olympus JPY 125.65B 5.75B Dec/2025
Pfizer USD 4.08B 894M Dec/2025
STAAR Surgical USD 59.38M 18.08M Sep/2025
Stryker USD 2.14B 150M Dec/2025
Surmodics USD 14.58M 2.05M Sep/2024
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 281.76M 66.68M Sep/2025
Terumo JPY 105.26B 7.38B Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025